503 results on '"Trama Annalisa"'
Search Results
52. Is low survival for cancer in Eastern Europe due principally to late stage at diagnosis?
53. Epidemiology of Testicular Cancer
54. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study
55. Improving treatment results with reference centres for rare cancers: where do we stand?
56. Resolution of Citalopram Sexual Adverse Effects With Low Dose of Cariprazine: A Case Report
57. Uncommon Cancers
58. Abstract 4529: The tumor molecular landscape of nasopharyngeal carcinoma (NPC) in endemic and non endemic areas
59. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers
60. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers:The protocol for the rare head and neck cancers
61. Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study
62. Survival of European adolescents and young adults diagnosed with cancer in 2000–07: population-based data from EUROCARE-5
63. Diagnosis and management of typical and atypical lung carcinoids
64. Thymoma and thymic carcinomas
65. Chordoma: update on disease, epidemiology, biology and medical therapies
66. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
67. Big Data in Head and Neck Cancer
68. Developing a comorbidity score in cancer patients using healthcare utilization databases during the COVID ‐19 pandemic: An experience from Italy
69. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
70. Cancer treatment data available in European cancer registries: Where are we and where are we going?
71. Accreditation for centers of sarcoma surgery
72. Is rare cancer care organized at national health system level? Multiple case study in six EU countries
73. Editorial: Real-World evidence in onco-hematological patients
74. Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments
75. Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort
76. Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group
77. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study
78. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study
79. Cancer Burden in Adolescents and Young Adults: A Review of Epidemiological Evidence
80. Benefits and Risks of Machine Learning Decision Support Systems
81. Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project
82. COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020
83. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population-based cohort
84. COVID-19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020
85. Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort
86. Data quality in rare cancers registration: the report of the RARECARE data quality study
87. Developing a comorbidity score in cancer patients using healthcare utilization databases during the COVID‐19 pandemic: An experience from Italy.
88. Embryonal cancers in Europe
89. Epidemiology of glial and non-glial brain tumours in Europe
90. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
91. Cancer Incidence, Survival, and Mortality Among Adolescents and Young Adults
92. A definitive prognostication system for patients with thoracic malignancies diagnosed with COVID-19: an update from the TERAVOLT registry
93. Cancer burden in adolescents and young adults in Europe
94. Rare cancers are not so rare: The rare cancer burden in Europe
95. Epidemiology of Rare Cancers in India and South Asian Countries - Remembering the Forgotten
96. Increased Incidence of Rare Cancer and Varied Age Distributions by Cancer Group in Hiroshima, Japan
97. Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort
98. Introducing Hepatitis B Virus Vaccine into the Expanded Programme on Immunization in Bangladesh: A Proposed Method to Evaluate Whether the Existing Infrastructure Has the Capacity
99. Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
100. Excess risk of subsequent malignant neoplasms in adolescent and young adult cancer survivors: Results from the first Italian population‐based cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.